Cargando…
Decreased Expression of Inhibitor of Caspase-Activated DNase (ICAD) in Renal Cell Carcinoma – Tissue Microarray of Human Samples
Although primary localised tumours of renal cell carcinoma (RCC) can be treated relatively successfully with surgery, metastatic RCC has poor prognosis because of late diagnosis and resistance to therapies. In the present study, we were interested in profiling the protein expression of “inhibitor of...
Autores principales: | Rajandram, Retnagowri, Razack, Azad H. A., Ng, Keng Lim, Gobe, Glenda C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Codon Publications
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5345525/ https://www.ncbi.nlm.nih.gov/pubmed/28326275 http://dx.doi.org/10.15586/jkcvhl.2016.47 |
Ejemplares similares
-
Evaluation of steroid hormones and their receptors in development and progression of renal cell carcinoma
por: Bennett, Nigel C, et al.
Publicado: (2014) -
Genetic and Chromosomal Aberrations and Their Clinical Significance in Renal Neoplasms
por: Yap, Ning Yi, et al.
Publicado: (2015) -
A Study on the Immunohistochemical Expressions of Leptin and Leptin Receptor in Clear Cell Renal Cell Carcinoma
por: Perumal, Komathi, et al.
Publicado: (2020) -
Auxin-induced Rapid Degradation of Inhibitor of Caspase-activated DNase (ICAD) Induces Apoptotic DNA Fragmentation, Caspase Activation, and Cell Death: A CELL SUICIDE MODULE
por: Samejima, Kumiko, et al.
Publicado: (2014) -
Potential Value of Visfatin, Omentin-1, Nesfatin-1 and Apelin in Renal Cell Carcinoma (RCC): A Systematic Review and Meta-Analysis
por: Chinapayan, Sugania Malar, et al.
Publicado: (2022)